We used an autochthonous mouse model in which undifferentiated soft-tissue sarcoma formation is initiated by deletion of both p53 alleles and expression of an oncogenic mutant Kras driven by either Flp recombinase or Cre recombinase (KP mouse). Here, TP53 is linked to soft tissue sarcoma.